Document is current
Any future updates will be listed below
-
Authors
Wang, Menghui
Li, Yueheng
Su, Junhui
Dong, Xinjue
Liu, Ao
Yang, Yuqi
Tang, Xinyi
Chen, Ruijie
Li, QingQuan
Wang, Hongshan
Xiao, Hong https://orcid.org/0000-0002-8187-8944
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82173161, 82473124)
Natural Science Foundation of Shanghai Municipality (22ZR1446800)
Shanghai Municipal Key Clinical Specialty (shslczdzk00101, shslczdzk06403)
Baoshan District Health Commission Key Subject Construction Project (BSZK-2023-A03)
- License Information
-
More Information
Article History
Received: 10 December 2024
Accepted: 1 March 2025
First Online: 11 April 2025
Declarations
:
: All daily animal care and the experimental procedures were approved by Institutional Animal Care and Use Committee of Fudan University. Animal handling was in accordance with ARRIVE Guidelines 2.0. The maximal tumor size was permitted by Institutional Animal Care and Use Committee of Fudan University, no subcutaneous tumors were exceeded 2,000 mm3 in this study. The human HCC tissue microarray was obtained from Zhongshan Hospital, Fudan University, with approval from the Ethics Committee of Zhongshan Hospital, Fudan University. Informed consent was obtained from patients before tissue collection.
: Not applicable.
: The authors declare that they have no competing interests.
